Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGDALENA: ICBT and Sertraline for Moderate Depression in Pregnancy
NCT02185547Phase 4Terminated
- Start
- Feb 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing ICBT + Zoloft with ICBT + Placebo (2 arms). Primary endpoint: Cognitive development at 2 years. Started Feb 2016; status: terminated.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02185547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185547.